Margaret Pax - 18 Mar 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
18 Mar 2024
Net transactions value
$0
Form type
4
Filing time
19 Mar 2024, 18:19:33 UTC
Previous filing
08 Nov 2023
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Award $0 +92 $0.000000 92 18 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Award $0 +195 $0.000000 195 18 Mar 2024 Common Stock 195 $194.25 Direct F2
transaction RGEN Stock Option (Right to Buy) Award $0 +2,236 $0.000000 2,236 18 Mar 2024 Common Stock 2,236 $194.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Pax was awarded 92 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 16, 2024, the date of the annual meeting of the Company's shareholders. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2 Award vests in full on May 16, 2024, the date of the annual meeting of the Company's shareholders.
F3 The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.